title: Implications of 'cell kill' for the treatment of acute myelogenous leukemia: can the cure rate be increased?
authors.affiliation: New York Medical College, Valhalla, N.Y.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Arlin
authors.forename: A
authors.initials: A
authors.lastname: Hagenbeek
authors.forename: E J
authors.initials: EJ
authors.lastname: Feldman
authors.forename: M
authors.initials: M
authors.lastname: Andreeff
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D012074:Remission Induction